JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.7 EUR | -0.50% |
|
-1.52% | -4.93% |
| 03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
d7a59f9a3d8a707f2a818507cae33.3AVT62AMzuM2wLG3DH5RN51auFcnydHFRTG0qHeMPeQ.ik0Lo1c6motR9PnTYBY3f-gb3CB4gbmLCGfc8QTTWcmPUCOYNUL6gGSC0g~15af5306f9bfee38513c63429ccd5fbe
